(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 10.75%-87.29K | 86.98%-259.05K | -2,710,787.50%-433.74K | -216,865.33%-2.53M | -3,441,884.62%-447.46K | -97.79K | -1.99M | 99.80%-16 | -1.17K | -13 |
Net income from continuing operations | 8.14%-204.56K | 91.64%-309.08K | 9.62%-425.69K | -2,288.00%-17.08M | -3,063.89%-12.69M | ---222.7K | ---3.7M | -3,060.95%-471.01K | ---715.38K | ---401.13K |
Asset impairment expenditure | ---- | ---- | ---- | --12.66M | ---- | ---- | ---- | ---- | --0 | --0 |
Remuneration paid in stock | -69.49%63.84K | -65.39%85.72K | --123.87K | --608.22K | --151.32K | --209.25K | --247.65K | --0 | --0 | ---- |
Other non cashItems | 101.66%7.74K | --8K | ---1.16K | --2.08M | ---573.97K | ---464.8K | ---- | ---- | ---- | ---- |
Change In working capital | -87.99%45.7K | 97.37%-43.68K | -127.76%-130.76K | -211.83%-798.69K | -97.38%10.52K | --380.45K | ---1.66M | 6,577.39%470.99K | --714.22K | --401.11K |
-Change in receivables | -94.76%1.51K | 122.84%4.52K | --15.33K | -215.73%-57.86K | ---66.99K | --28.91K | ---19.79K | --0 | --50K | --0 |
-Change in prepaid assets | 130.21%5.59K | 57.55%-7.42K | --2.94K | ---30.37K | --5.6K | ---18.5K | ---17.47K | --0 | --0 | ---- |
-Change in payables and accrued expense | -89.57%38.6K | 97.49%-40.78K | -131.64%-149.03K | -206.96%-710.45K | -82.07%71.9K | --370.04K | ---1.62M | 7,825.74%470.99K | --664.22K | --401.11K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 10.75%-87.29K | 86.98%-259.05K | -2,710,787.50%-433.74K | -216,865.33%-2.53M | -3,441,884.62%-447.46K | ---97.79K | ---1.99M | 99.80%-16 | ---1.17K | ---13 |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 3.4M | 0 | -354.12K | 0 | 0 | ||||
Net business purchase and sale | --0 | ---- | ---- | --3.4M | --0 | ---354.12K | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | ---- | ---- | --3.4M | --0 | ---354.12K | ---- | ---- | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -45.09%29.46K | -109.41K | -88.72K | 53.65K | 0 | |||||
Net issuance payments of debt | ---- | ---- | ---- | ---109.41K | ---88.72K | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -45.09%29.46K | ---- | ---- | ---109.41K | ---88.72K | --53.65K | ---- | ---- | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -96.51%60.68K | 7,712.23%322.02K | 18,957.36%774.49K | -23.87%4.06K | 33,583.04%1.3M | --1.74M | --4.12K | -88.05%4.06K | --5.34K | --3.86K |
Current changes in cash | 85.48%-57.83K | -115.31%-259.05K | -2,710,787.50%-433.74K | 64,957.36%757.53K | -4,124,353.85%-536.18K | ---398.26K | --1.69M | 99.80%-16 | ---1.17K | ---13 |
Effect of exchange rate changes | 100.25%95 | -105.53%-2.29K | -25,409.46%-18.73K | 12,263.21%12.89K | 4,472.56%9.83K | ---38.36K | --41.35K | --74 | ---106 | --215 |
End cash Position | -99.77%2.95K | -96.51%60.68K | 7,712.23%322.02K | 18,957.36%774.49K | 18,957.36%774.49K | --1.3M | --1.74M | -84.24%4.12K | --4.06K | --4.06K |
Free cash from | 10.75%-87.29K | 86.98%-259.05K | -2,710,787.50%-433.74K | -216,865.33%-2.53M | -3,441,884.62%-447.46K | ---97.79K | ---1.99M | 99.80%-16 | ---1.17K | ---13 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data